Similar articles for PMID: 19013938

Year	Number of Results
1997	1
1999	2
2000	2
2002	1
2003	2
2004	1
2005	1
2006	12
2007	19
2008	15
2009	18
2010	7
2011	3
2012	1
2013	1
2014	1
2017	1
2018	1
2019	1
2024	0

1

Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Dwoskin LP, Pivavarchyk M, Joyce BM, Neugebauer NM, Zheng G, Zhang Z, Bardo MT, Crooks PA. Dwoskin LP, et al. Nebr Symp Motiv. 2009;55:31-63. doi: 10.1007/978-0-387-78748-0_4. Nebr Symp Motiv. 2009. PMID: 19013938 Free PMC article. No abstract available.

2

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.

Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR. Nides M, et al. Arch Intern Med. 2006 Aug 14-28;166(15):1561-8. doi: 10.1001/archinte.166.15.1561. Arch Intern Med. 2006. PMID: 16908788 Clinical Trial.

3

Nicotinic receptor antagonists as treatments for nicotine abuse.

Crooks PA, Bardo MT, Dwoskin LP. Crooks PA, et al. Adv Pharmacol. 2014;69:513-51. doi: 10.1016/B978-0-12-420118-7.00013-5. Adv Pharmacol. 2014. PMID: 24484986 Free PMC article. Review.

4

Drugs for tobacco dependence.

[No authors listed] [No authors listed] Treat Guidel Med Lett. 2008 Sep;6(73):61-6. Treat Guidel Med Lett. 2008. PMID: 18719526 Review. No abstract available.

5

A second varenicline trial.

O'Brien CP. O'Brien CP. Curr Psychiatry Rep. 2007 Oct;9(5):346-7. Curr Psychiatry Rep. 2007. PMID: 17915071 No abstract available.

6

[Medication for ending tobacco dependency. Current state].

Camarelles Guillem F. Camarelles Guillem F. Aten Primaria. 2005 Jun 30;36(2):62-3. doi: 10.1157/13076595. Aten Primaria. 2005. PMID: 15989825 Free PMC article. Spanish. No abstract available.

7

Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Chatterjee S, Bartlett SE. Chatterjee S, et al. CNS Neurol Disord Drug Targets. 2010 Mar;9(1):60-76. doi: 10.2174/187152710790966597. CNS Neurol Disord Drug Targets. 2010. PMID: 20201817 Free PMC article. Review.

8

Non-nicotinic therapies for smoking cessation.

Siu EC, Tyndale RF. Siu EC, et al. Annu Rev Pharmacol Toxicol. 2007;47:541-64. doi: 10.1146/annurev.pharmtox.47.120505.105354. Annu Rev Pharmacol Toxicol. 2007. PMID: 17209799 Review.

9

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE. Garrison GD, et al. Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Clin Ther. 2009. PMID: 19393839 Review.

10

Varenicline for tobacco dependence.

Hays JT, Ebbert JO. Hays JT, et al. N Engl J Med. 2008 Nov 6;359(19):2018-24. doi: 10.1056/NEJMct0800146. N Engl J Med. 2008. PMID: 18987369 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year